expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low …

to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden's public prices for pharmaceuticals …, assesses the degree to which Sweden has achieved certain policy goals, and puts forth some key findings and conclusions. Thanks …. Pharmaceutical expenditure per capita in Sweden is lower than the OECD average. Only five OECD countries devote less of their …

This paper investigates price patterns of off-patent pharmaceuticals in Sweden. I show that price dynamics are … competition in which the demand for pharmaceuticals incorporates the known biases of consumers: habit persistence and brand … preferences. Using the regulated market of Swedish pharmaceuticals, I show that price may help in identifying possible tacit …

the first vaccine against polio in Sweden (birth cohorts 1937-1966) until adulthood in order to quantify the causal effect …